Enoxaparin therapy for arterial thrombosis in infants with congenital heart disease

Intensive Care Medicine

Volumn 33, Issue 11, 2007, Pages 1978-1984

  Bontadelli, Joe ^a   Moeller, Alexander ^a   Schmugge, Markus ^a   Schraner, Thomas ^a   Kretschmar, Oliver ^a   Bauersfeld, Urs ^a   Bernet Buettiker, Vera ^a   Albisetti, Manuela ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Artery; Enoxaparin; Infants; Low molecular weight heparin; Newborns; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 10A; DALTEPARIN; ENOXAPARIN; HEPARIN;

AORTA; ARTERY THROMBOSIS; ARTICLE; BLEEDING; CATHETER COMPLICATION; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEMORAL ARTERY; FOLLOW UP; HEART CATHETERIZATION; HUMAN; ILIAC ARTERY; INDWELLING CATHETER; INFANT; INTENSIVE CARE; MALE; NEWBORN; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SWITZERLAND; UNIVERSITY HOSPITAL;

ANTICOAGULANTS; COHORT STUDIES; CORONARY THROMBOSIS; ENOXAPARIN; FEMALE; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; MALE; OUTCOME ASSESSMENT (HEALTH CARE); SWITZERLAND;

EID: 35448945312     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0718-8     Document Type: Article

References (23)

1. Monagle P (2003) Thrombosis in pediatric cardiac patients. Semin Thromb Hemost 29:547-555
2. Albisetti M, Schmugge M, Haas R, Eckhardt BP, Bauersfeld U, Baenziger O, Hug MI (2005) Arterial thromboembolic complications in critically ill children. J Crit Care 20:296-300
3. Price V, Massicotte MP (2003) Arterial thromboembolism in the pediatric population. Semin Thromb Hemost 29:557-565
4. Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD (2004) Antithrombotic therapy in children. Chest 126:645S-687S
5. Hirsh J, Crowter MA (2000) Arterial thromboembolism. In: Hoffman R, Benz EJ, Shattil SI, Furie B, Cohen HJ, Silberstein LE, McGlave P (eds) Hematology: basic principle and practice, 3rd edn. Churchill Livingstone, Philadelphia, pp 2089-2096
6. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L (1992) Maturation of the hemostatic system during childhood. Blood 80:1998-2005
7. Albisetti M (2003) The fibrinolytic system in children. Semin Thromb Hemost 29:339-347
8. Albisetti M (2006) Thrombolytic therapy in children. Thromb Res 118:95-105
9. Weitz JI (1997) Low-molecular-weight heparins. N Engl J Med 337:688-698
10. Albisetti M, Andrew M (2002) Low molecular weight heparin in children. Eur J Pediatr 161:71-77
11. Bontadelli J, Moeller A, Schmugge M, Kretschmar O, Bauersfeld U, Schraner T, Bernet-Buettiker V, Albisetti M (2006) Use of enoxaparin in the treatment of catheter-related arterial thrombosis in infants with congenital heart disease [Abstract]. Cardiol Young (Suppl) 16(2):27
12. Monagle P, Michelson AD, Bovill E, Andrew M (2001) Antithrombotic therapy in children. Chest 119:344-370S
13. Streif W, Goebel G, Chan AKC, Massicotte MP (2003) Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients. Arch Dis Child Fetal Neonatal Ed 88:F365-F370
14. Michaels LA, Gurian M, Hegyi T, Drachtman RA (2004) Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant. Pediatrics 114:703-707
15. Baumgartner HR (1973) The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc Res 5:167-179
16. Hirsh J, Levine MN (1992) Low molecular weight heparin. Blood 79:1-17
17. Mirshahi M, Soria J, Neuhart E, Steg PG, Jacob P, Combe S, Soria C (1992) Effect of heparin and enoxaparin on platelet interaction with fibrin clots. Thromb Res 65:187-191
18. Serra A, Esteve J, Reverter JC, Lozano M, Escolar G, Ordinas A (1997) Differential effect of a low-molecular-weight heparin (dalteparin) and unfractionated heparin on platelet interaction with the subendothelium under flow conditions. Thromb Res 87:405-410
19. Jang IK, Gold HK, Ziskind AA, Fallon JT, Holt RE, Leinbach RC, May JW, Collen D (1989) Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis. Circulation 79:920-928
20. Massicotte P, Adams M, Marzinotto V, Brooker LA, Andrew M (1996) Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 128:313-318
21. Punzalan RC, Hillery CA, Montgomery RR, Scott JP, Gill JC (2000) Low-molecular-weight heparin in thrombotic disease in children and adolescents. J Pediatr Hematol Oncol 22:137-142
22. Dix D, Andrew M, Marzinotto V, Charpentier K, Bridge S, Monagle P, de Veber G, Leaker M, Chan AKC, Massicotte P (2000) The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr 136:439-445
23. Ho SH, Wu JK, Hamilton DP, Dix DB, Wadsworth LD (2004) An assessment of published dosage guidelines for enoxaparin. J Pediatr Hematol Oncol 26:561-566